TechConnect World 2020
Co-Located with Nanotech 2021Co-Located with Nanotech 2021 SBIR/STTRSBIR/STTR AI TechConnectAI TechConnect
Nanotech 2020
 
 

AI for Biomaterials and Drug Design

AI Biomaterials and Drug Design

Symposium Co-Chairs

Payel DasPayel Das
IBM Thomas J Watson Research Center

Sarah TaoSarah Tao
Technology Lead
Sanofi

Key Speakers (preliminary program)

Philip M. KimMachine learning methods for the de-novo design of proteins and antibodies
Philip M. Kim
Professor, Donnelly Centre for Cellular and Biomolecular Research, University of Toronto

Debora S. MarksDebora S. Marks
Associate Professor
Harvard Medical School

Connor ColeyChemical Discovery and AI-Assisted Chemical Synthesis
Connor Coley
Assistant Professor of Chemical Engineering, Massachusetts Institute of Technology

Glenn ButterfossCombining machine learning with other computational methods for drug design
Glenn Butterfoss
Senior Computational Biologist, ProteinQure

Advances in computational power coupled with big data analysis and innovations in machine learning, modeling and simulation approaches are enabling artificial intelligence to revolutionize the biomaterials and drug discovery and development process.

Submit your abstract and join researchers from around the world as we highlight the latest developments in this area.

 
2020 Sponsors & Partners
 

2019 SBIR/STTR Agency Partners:

SBIR/STTR Agency Partners